President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the ...

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

By Steve Holland, Michael Erman and Patrick Wingrove WASHINGTON (Reuters) -U.S. President Donald Trump signed a wide-reaching ...

The president is planning Monday to revive a plan from his first term, which would peg the prices the United States pays for ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

The move would align prescription costs in the US with the costs of other countries, according to the administration.

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private ...